Arbutus Provides 2025 Corporate and Financial Update
Provided By GlobeNewswire
Last update: Jan 13, 2025
Initiating Phase 2b clinical trial in first half of 2025 after achieving a meaningful functional cure rate in cHBV patients treated with imdusiran and interferon
Read more at globenewswire.com
